The great debate
There are a variety of obstacles to the commercialisation of advanced therapies. Dr Christian K Schneider reports on an industry panel debate that thrashed out strategies for a viable path to market.
There are a variety of obstacles to the commercialisation of advanced therapies. Dr Christian K Schneider reports on an industry panel debate that thrashed out strategies for a viable path to market.
We are now Cencora PharmaLex
PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.